Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder

Although the physiologic role of muscarinic receptors in bladder function and the therapeutic efficacy of muscarinic antagonists for the treatment of overactive bladder are well established, the role of β3-adrenergic receptors (β3ARs) and their potential as therapeutics is just emerging. In this man...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pharmacology and experimental therapeutics 2017-02, Vol.360 (2), p.346-355
Hauptverfasser: Di Salvo, J., Nagabukuro, H., Wickham, L.A., Abbadie, C., DeMartino, J.A., Fitzmaurice, A., Gichuru, L., Kulick, A., Donnelly, M.J., Jochnowitz, N., Hurley, A.L., Pereira, A., Sanfiz, A., Veronin, G., Villa, K., Woods, J., Zamlynny, B., Zycband, E., Salituro, G.M., Frenkl, T., Weber, A.E., Edmondson, S.D., Struthers, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!